Penumbra
Alameda
About Penumbra
Penumbra designs, develops, manufactures and markets medical devices for interventional therapies addressing neurovascular and vascular conditions. The company’s product range includes mechanical thrombectomy systems, peripheral thrombectomy tools, access catheters, embolization devices and neurosurgical tools used by healthcare providers and hospitals globally. Its offerings support procedures such as clot removal in acute ischemic stroke, vascular embolization and other minimally invasive interventions. Penumbra sells through direct sales teams and distributor networks, and provides clinical support to practitioners integrating its technologies into treatment workflows.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $2.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2021)
- Ticker: nyse:PEN
- Website: penumbrainc.com
- Phone: 5107483232
Industries & Categories
Biotechnology, Developer Platform, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/penumbra-123516 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.